Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0000950170-24-005296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-18 | 2024-01-16 | MDGL | Taub Rebecca | Pres, CMO, R, D, Dir | F - Tax | $243.92 | -1,546 | 15.0K | -9% | -$377.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-16 | F | D | 1,546 | $243.92 | 15,001 | D | — | — | (F2) Represents restricted stock units granted to the Reporting Person on January 16, 2023. |